Suppr超能文献

沙苑子黄酮对大鼠抗肝纤维化的作用。

Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.

作者信息

Liu Chun-Yu, Gu Zhen-Lun, Zhou Wen-Xuan, Guo Ci-Yi

机构信息

Department of Pharmacology, Medical College of Suzhou University, Suzhou 215007, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2005 Oct 7;11(37):5782-6. doi: 10.3748/wjg.v11.i37.5782.

Abstract

AIM

To observe the anti-liver fibrosis effect of Astragalus complanatus flavonoids (ACF) in rats.

METHODS

The liver fibrosis model in rats was established by injecting interperitoneally 0.2 mL/100 g 0.5% dimethylnitrosamine, thrice a week. Meanwhile, the rats were administered ACF (30, 60, 120 mg/kg) or colchicine (0.1 mg/kg) once a day for 1 mo. Serum N-propeptide of type I procollagen (PINP) and type III procollagen (PIIINP) were measured using ELISA. Malondialdehyde (MDA) and superoxide dismutase (SOD) in hepatic tissue were evaluated. Matrix metal protease-1 (MMP-1) mRNA expression was assayed by RT-PCR and the protein expression of tissue inhibitor of metal protease-1 (TIMP-1) was analyzed by immunohistochemistry.

RESULTS

In the ACF groups, SOD activity increased and MDA content decreased in comparison to the liver fibrosis model group. The serum PINP and PIIINP contents in ACF-2 and -3 group decreased compared to those in model group. In ACF-2 and -3 group, the expression of MMP-1 mRNA increased significantly and the protein expression of TIMP-1 decreased compared to that in model group.

CONCLUSION

The antifibrotic mechanisms of ACF are associated with its influence on lipid peroxidation and collagen synthesis and degradation.

摘要

目的

观察沙苑子黄酮(ACF)对大鼠抗肝纤维化的作用。

方法

通过腹腔注射0.2 mL/100 g 0.5%二甲基亚硝胺,每周3次,建立大鼠肝纤维化模型。同时,大鼠每天给予ACF(30、60、120 mg/kg)或秋水仙碱(0.1 mg/kg),持续1个月。采用酶联免疫吸附测定法检测血清I型前胶原氨基端前肽(PINP)和III型前胶原氨基端前肽(PIIINP)。评估肝组织中的丙二醛(MDA)和超氧化物歧化酶(SOD)。通过逆转录-聚合酶链反应检测基质金属蛋白酶-1(MMP-1)mRNA表达,并通过免疫组织化学分析金属蛋白酶组织抑制剂-1(TIMP-1)的蛋白表达。

结果

与肝纤维化模型组相比,ACF各剂量组中SOD活性升高,MDA含量降低。与模型组相比,ACF-2组和ACF-3组血清PINP和PIIINP含量降低。与模型组相比,ACF-2组和ACF-3组MMP-1 mRNA表达显著增加,TIMP-1蛋白表达降低。

结论

ACF的抗纤维化机制与其对脂质过氧化以及胶原合成和降解的影响有关。

相似文献

1
Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.
World J Gastroenterol. 2005 Oct 7;11(37):5782-6. doi: 10.3748/wjg.v11.i37.5782.
6
Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.
J Pharm Pharmacol. 2012 Jun;64(6):811-20. doi: 10.1111/j.2042-7158.2012.01490.x. Epub 2012 Apr 5.

引用本文的文献

1
: A review of its anti-fibrosis properties.
Front Pharmacol. 2022 Sep 7;13:976561. doi: 10.3389/fphar.2022.976561. eCollection 2022.
2
Characterization of the complete plastid genome of the perennial herb Bunge (Fabales: Fabaceae).
Mitochondrial DNA B Resour. 2021 Nov 18;6(12):3440-3442. doi: 10.1080/23802359.2021.1961628. eCollection 2021.
5
Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.
J Tradit Complement Med. 2017 Nov 22;8(3):352-360. doi: 10.1016/j.jtcme.2017.07.002. eCollection 2018 Jul.
6
Identification of bioactives from L.f. and their antioxidant, anti-inflammatory and anti-proliferative effects.
J Food Sci Technol. 2017 Dec;54(13):4315-4323. doi: 10.1007/s13197-017-2902-3. Epub 2017 Oct 31.
7
Vascular protective effects of and its main constituents in rats with chronic hyperhomocysteinemia.
Exp Ther Med. 2017 Sep;14(3):2401-2407. doi: 10.3892/etm.2017.4739. Epub 2017 Jul 9.
9
Flavonoids from the Genus Astragalus: Phytochemistry and Biological Activity.
Pharmacogn Rev. 2016 Jan-Jun;10(19):11-32. doi: 10.4103/0973-7847.176550.

本文引用的文献

1
Structure and function of hepatic stellate cells.
Med Electron Microsc. 2004 Mar;37(1):3-15. doi: 10.1007/s00795-003-0230-3.
2
Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.
World J Gastroenterol. 2004 Apr 1;10(7):1037-42. doi: 10.3748/wjg.v10.i7.1037.
3
The effect of taurine treatment on oxidative stress in experimental liver fibrosis.
Hepatol Res. 2004 Apr;28(4):207-215. doi: 10.1016/j.hepres.2003.11.012.
4
Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells.
World J Gastroenterol. 2004 Feb 15;10(4):610-3. doi: 10.3748/wjg.v10.i4.610.
6
Experimental study of effect of Ganyanping on fibrosis in rat livers.
World J Gastroenterol. 2003 Jun;9(6):1292-5. doi: 10.3748/wjg.v9.i6.1292.
8
Antifibrogenic therapies in chronic HCV infection.
Curr Drug Targets Infect Disord. 2001 Aug;1(2):227-40. doi: 10.2174/1568005014606053.
9
Developing strategies for liver fibrosis treatment.
Expert Opin Investig Drugs. 2002 Nov;11(11):1575-85. doi: 10.1517/13543784.11.11.1575.
10
Antifibrotic properties of botanicals in chronic liver disease.
Hepatogastroenterology. 2002 Jul-Aug;49(46):1102-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验